Does Coronavirus Disease 2019 (COVID-19) Pandemic Cause a Delay in the Diagnosis of Gastric Cancer Patients?

NCT04797624 | Completed DMC

• 1 other identifier: 1248
• Study Type: observational
• Target: 146
• Locations: 1 country
• Sites: 1

Brief Summary

The aim of this study is to analyze whether COVID-19 causes a delay in the diagnosis of gastric cancer patients particularly in the TNM staging of the tumor, or not and to compare the number of newly diagnosed patients with gastric cancer before and during the COVID-19 pandemic period.

Conditions

Stomach Cancer; Corona Virus Infection

Keywords

gastric surgery; COVID-19; SARS-COV-2; pandemic; stomach surgery; cancer surgery

Outcome Measures

Primary Outcomes (2)

• Comparison of the mean monthly numbers of newly diagnosed gastric cancer patients between the groups

  numbers of newly diagnosed gastric cancer

  from March 1, 2020 to December 31, 2020 -from January 1, 2019 to December 31, 2019

• Comparison of the clinical staging and pathologic TNM staging of the patients

  Clinical staging was determined based on the results of a physical exam, biopsy, and imaging tests including computed tomography (CT), PET CT, endoscopy and the endoscopic ultrasound. Surgical stage refers to the pathologic stage of the surgical specimen determined based on the American Joint Committee on Cancer (AJCC) TNM system.

  from March 1, 2020 to December 31, 2020 -from January 1, 2019 to December 31, 2019

Secondary Outcomes (1)

• Comparison of the demographic data

  from March 1, 2020 to December 31, 2020 -from January 1, 2019 to December 31, 2019

Study Arms (2)

Baseline group

The baseline group included the patients diagnosed with gastric cancer between January 1, 2019, and December 31, 2019, in the pandemic group at the Adana City Training and Research Hospital, Department of General Surgery, Divisions of Gastroenterological Surgery and Surgical Oncology. Gastric cancer surgery for adequate patients.

Procedure: Gastric cancer surgery

Pandemic group

The pandemic group included the patients diagnosed with gastric cancer during the period between March 1, 2020, and December 31, 2020, in the pandemic group at the Adana City Training and Research Hospital, Department of General Surgery, Divisions of Gastroenterological Surgery and Surgical Oncology. Gastric cancer surgery for adequate patients.

Procedure: Gastric cancer surgery

Interventions

Gastric cancer surgery PROCEDURE

Appropriate gastric cancer surgery types for the convenient patients

Baseline group; Pandemic group

Eligibility Criteria

• Age: 18 Years - 95 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

newly diagnosed gastric cancer patients

You may qualify if:

• Patients newly diagnosed with gastric cancer at specified intervals will be included in the study.

You may not qualify if:

• Having an additional second primary tumor

Sponsors & Collaborators

• Adana City Training and Research Hospital: lead

Study Sites (1)

Adana City Training and Research Hospital

Adana, Yuregir, 01370, Turkey (Türkiye)

Location

Related Publications (3)

• Feletto E, Grogan P, Nickson C, Smith M, Canfell K. How has COVID-19 impacted cancer screening? Adaptation of services and the future outlook in Australia. Public Health Res Pract. 2020 Dec 9;30(4):3042026. doi: 10.17061/phrp3042026.

  PMID: 33294902 BACKGROUND

• Vecchione L, Stintzing S, Pentheroudakis G, Douillard JY, Lordick F. ESMO management and treatment adapted recommendations in the COVID-19 era: colorectal cancer. ESMO Open. 2020 May;5(Suppl 3):e000826. doi: 10.1136/esmoopen-2020-000826.

  PMID: 32457036 BACKGROUND

• Dinmohamed AG, Visser O, Verhoeven RHA, Louwman MWJ, van Nederveen FH, Willems SM, Merkx MAW, Lemmens VEPP, Nagtegaal ID, Siesling S. Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands. Lancet Oncol. 2020 Jun;21(6):750-751. doi: 10.1016/S1470-2045(20)30265-5. Epub 2020 Apr 30. No abstract available.

  PMID: 32359403 BACKGROUND

MeSH Terms

Conditions

Stomach Neoplasms; Coronavirus Infections; COVID-19

Condition Hierarchy (Ancestors)

Gastrointestinal Neoplasms; Digestive System Neoplasms; Neoplasms by Site; Neoplasms; Digestive System Diseases; Gastrointestinal Diseases; Stomach Diseases; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Virus Diseases; Infections; Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Lung Diseases; Respiratory Tract Diseases

Study Officials

• Ahmet Seker, MD

  Adana City Training and Research Hospital

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Ahmet Seker, Associate Professor, MD, Department of Gastroenterological Surgery

Study Record Dates

• First Submitted: March 12, 2021
• First Posted: March 15, 2021
• Study Start: January 15, 2021
• Primary Completion: February 15, 2021
• Study Completion: February 15, 2021
• Last Updated: March 15, 2021

Record last verified: 2021-03

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)